Evidence Synthesis
ORCHPHARMA closed at 1002.05 INR, up from 980.05 INR.
The company's gross margin accelerated to 52.99%, up from . Marginal operating leverage also accelerated to -12.26%, up from -29.57%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 01:47
Narrative updating · score is newerSee how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ORCHPHARMA closed at 1002.05 INR, up from 980.05 INR.
The company's gross margin accelerated to 52.99%, up from . Marginal operating leverage also accelerated to -12.26%, up from -29.57%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 52.99 % | -12.26 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -12.26 % | -29.57 | ▲ |
| REVENUE_GROWTH_YOY | -1.5 % | — | - |
| EPS_ACTUAL | -1.13 INR | -1.085 | ▼ |
| EPS_SURPRISE_PERCENT | -1.39 % | -2.615 | ▲ |
| PRICE_CHANGE_PERCENT | 2.245 % | — | - |
| DAILY_VOLUME | 1,06,269 shares | 1,96,363 | ▼ |
| CLOSE_PRICE | 1,002.05 INR | 980.05 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 3 | ▼ |
| TARGET_PRICE_PREMIUM | -2.6 % | — | - |